Cinta Hierro Selected Research

Cinta Hierro Research Topics

15	Neoplasms (Cancer) 01/2022 - 12/2015
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2022
2	Cholangiocarcinoma 01/2022 - 01/2019
2	Carcinoma (Carcinomatosis) 01/2019 - 08/2015
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Intestinal Obstruction (Obstruction, Intestinal) 01/2021
1	Lymphoma (Lymphomas) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Esophageal Neoplasms (Esophageal Cancer) 04/2019
1	Disease Progression 01/2019
1	Exanthema (Rash) 01/2018
1	Fatigue 01/2018
1	Oncogene Addiction 02/2017
1	Stomach Neoplasms (Stomach Cancer) 01/2016

2	Biological ProductsIBA 01/2021 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2021 - 03/2017
2	pembrolizumabIBA 04/2019 - 03/2017
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2019 - 12/2015
1	Messenger RNA (mRNA)IBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	futibatinibIBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	spartalizumabIBA 01/2021
1	AlbuminsIBA 01/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	AntibodiesIBA 01/2020
1	PlatinumIBA 04/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	erdafitinibIBA 01/2019
1	CH5183284IBA 01/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2018
1	VaccinesIBA 03/2017
1	atezolizumabIBA 03/2017
1	NivolumabIBA 03/2017
1	IpilimumabIBA 03/2017
1	Pharmaceutical PreparationsIBA 02/2017
1	Biomarkers (Surrogate Marker)IBA 02/2017
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2015